These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19104402

  • 21. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD, Lyden ER, Gulizia JM, McCashland TM.
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssiere L, Durand D, Izopet J, Rostaing L.
    Transplant Proc; 2004 Nov; 36(9):2757-61. PubMed ID: 15621141
    [Abstract] [Full Text] [Related]

  • 23. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I, Hsaiky L, Brown K, Abouljoud M.
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [Abstract] [Full Text] [Related]

  • 24. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcome of immunosuppression withdrawal after liver transplantation.
    Girlanda R, Rela M, Williams R, O'Grady JG, Heaton ND.
    Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439
    [Abstract] [Full Text] [Related]

  • 26. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.
    Transplant Proc; 2008 May; 40(6):1974-5. PubMed ID: 18675104
    [Abstract] [Full Text] [Related]

  • 27. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 28. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [Abstract] [Full Text] [Related]

  • 29. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
    Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M.
    J Hepatol; 2006 Apr; 44(4):702-9. PubMed ID: 16473433
    [Abstract] [Full Text] [Related]

  • 30. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF, Ataide EC, Leonardi MI, Stucchi R, Sevá-Pereira T, Pereira IW, Cardoso AR, Caruy CA, Luzo A, Leonardi LS.
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [Abstract] [Full Text] [Related]

  • 31. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I, Ulloa E, Colina F, Abradelo M, Jiménez C, Gimeno A, Meneu JC, Lumbreras C, Solís-Herruzo JA, Moreno E.
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [Abstract] [Full Text] [Related]

  • 32. Potential applications of extracorporeal photopheresis in liver transplantation.
    Urbani L, Mazzoni A, Colombatto P, Biancofiore G, Bindi L, Tascini C, Menichetti F, Brunetto M, Scatena F, Filipponi F.
    Transplant Proc; 2008 May; 40(4):1175-8. PubMed ID: 18555142
    [Abstract] [Full Text] [Related]

  • 33. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J.
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [Abstract] [Full Text] [Related]

  • 34. Posttransplantation prevention and treatment of recurrent hepatitis C.
    Burroughs AK.
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S35-40. PubMed ID: 11084083
    [Abstract] [Full Text] [Related]

  • 35. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
    Abu-Elmagd KM, Mazariegos G, Costa G, Soltys K, Bond G, Sindhi R, Green M, Jaffe R, Wu T, Koritsky D, Matarese L, Schuster B, Martin L, Dvorchik I, Nalesnik MA.
    Transplantation; 2009 Oct 15; 88(7):926-34. PubMed ID: 19935465
    [Abstract] [Full Text] [Related]

  • 36. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O.
    Liver Transpl; 2007 Feb 15; 13(2):294-301. PubMed ID: 17256784
    [Abstract] [Full Text] [Related]

  • 37. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM.
    Liver Transpl; 2004 Dec 15; 10(12):1497-503. PubMed ID: 15558835
    [Abstract] [Full Text] [Related]

  • 38. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.
    Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH.
    Transplantation; 2009 Apr 27; 87(8):1174-9. PubMed ID: 19384164
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, Rossi M, Lake J, Munn S, Mühlbacher F, Leonardi L, Cillo U.
    Transplant Proc; 2006 Nov 27; 38(9):2964-7. PubMed ID: 17112875
    [Abstract] [Full Text] [Related]

  • 40. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD.
    Liver Transpl; 2006 Jul 27; 12(7):1104-11. PubMed ID: 16710855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.